相关实验视频

Updated: Mar 10, 2026

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

RNA引导的清晰度:在临床外基因组测序中解决变异不确定性的潜力

Grace E VanNoy¹, Catherine Schultz¹, Brooklynn Gasser¹

¹Ambry Genetics, Aliso Viejo, CA.

Genetics in medicine open

|March 9, 2026

概括

RNA分析可以通过澄清具有不确定的意义 (VUS) 的变异来改善罕见疾病的外体序列 (ES). 这项研究表明,将RNA分析与临床ES整合起来,可以提高诊断准确度和有意义的患者报告.

科学领域:

基因组学就是基因组学.
罕见疾病的诊断罕见疾病的诊断
分子生物学分子生物学

背景情况:

外体序列测序 (ES) 对于诊断罕见疾病至关重要.
RNA分析显示增加诊断产量的承诺,但面临实施挑战.
有限的研究量化了RNA分析在临床环境中的实际实用性和障碍.

研究的目的:

追溯评估RNA分析对临床外基因组测序 (ES) 变体解释的影响.
根据特定标准,量化符合RNA分析的变异比例.
评估RNA分析在重新分类具有不确定的意义的变异 (VUS) 中的有效性.

主要方法:

在5年内从临床ES报告的变异的回顾性分析.
根据结合基因影响,血液中的基因表达,基因特征和功能丧失 (LOF) 机制,评估了变种是否符合RNA分析的资格.
符合条件的变体,特别是VUS,通过回顾性RNA分析进行了评估.

主要成果:

报告的变异中有7.6%符合RNA分析的条件.
在9例病例中进行了RNA分析,其中7例是VUS.
在分析的VUS中,71.4%升级为可能致病的,而28.6%仍然是VUS.
两种可能的致病变体仍然被归类为这样的.

结论:

假定拼接变体是临床ES中VUS的重要组成部分,通常在血液表达的LOF基因中发现.
将RNA分析与临床ES整合起来,可以澄清超过5%的报告VUS.
RNA分析是一种可行的策略,可以提高诊断准确度,并为罕见疾病患者提供临床上有意义的报告.

关键词:

外体序列排序是如何进行的这是一个RNARNARNARNARNA.罕见疾病是一种罕见的疾病.变体分类的变体分类

更多相关视频

Using a Fluorescent PCR-capillary Gel Electrophoresis Technique to Genotype CRISPR/Cas9-mediated Knockout Mutants in a High-throughput Format

Using a Fluorescent PCR-capillary Gel Electrophoresis Technique to Genotype CRISPR/Cas9-mediated Knockout Mutants in a High-throughput Format

Published on: April 8, 2017

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...